Surgery Doctors in Anchorage, AK Accepting Medicare

50 Surgery doctors found. Showing 41 - 50

Sheridan Morgan, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-602-1046

Martin Herbert Tieva, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-563-2662

Robert R Artwohl, MD PC Surgery Medicare: Accepting Medicare Assignments Practice Location: 3300 Providence Dr, Suite 309, Anchorage, AK 99508 Phone: 907-261-5035    Fax: 907-261-5658

Sherry Johnson, D.O. FACS Surgery Medicare: Accepting Medicare Assignments Practice Location: 2925 Debarr Rd Ste D350, Anchorage, AK 99508 Phone: 907-276-3676    Fax: 907-276-3679

Dr. Laurie Jane Bleicher, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3851 Piper St, Suite U-422, Anchorage, AK 99508 Phone: 907-561-2533

Jana K Cole, MD Surgery - Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 2741 Debarr Rd Ste C215, Anchorage, AK 99508 Phone: 907-563-2002    Fax: 907-562-7628

Dr. David C Wrigley, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3300 Providence Dr, Suite 213, Anchorage, AK 99508 Phone: 907-743-0740    Fax: 907-743-0741

Dr. John P Muffoletto, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2751 Debarr Rd, Suite 290, Anchorage, AK 99508 Phone: 907-276-1046    Fax: 907-222-6898

Ashok Rai, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3260 Providence Dr Ste 523, Anchorage, AK 99508 Phone: 907-222-1714    Fax: 907-222-1740

Ms. April Lizette Rodriguez, M.D. Surgery - Vascular Surgery Medicare: Accepting Medicare Assignments Practice Location: 4001 Laurel St Ste 204, Anchorage, AK 99508 Phone: 907-562-8346    Fax: 907-562-8347

News Archive

Pradaxa capsules receive FDA approval for reducing stroke and systemic embolism risk in AFib patients

The U.S. Food and Drug Administration (FDA) has approved Pradaxa (dabigatran etexilate) capsules to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AFib).

High pressure technology holds promise for decontamination of dairy products

The AZTI-Tecnalia technological centre, in a project undertaken by the Tecnolat and Llet de Catalunya dairy product companies within the FUTURAL project, has verified that, as an alternative to the traditional heat treatment for decontamination of a number of dairy products, high pressure technology is highly recommendable. In fact, according to a press release from Tecnolat, the results, especially with ready-to-eat fruit products and in the inactivation of moulds and yeasts in other dairy products, "were highly positive and promising".

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Janssen-Cilag International NV announced today that the European Commission has approved INVOKANA (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control[1]. Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.

New data on Posiphen for Alzheimer's disease treatment to be presented at Biotech Symposium

QR Pharma, Inc., a clinical stage specialty pharmaceutical company committed to developing therapeutics with novel approaches for the treatment of Alzheimer's disease (AD), Parkinson's disease (PD) and other neurodegenerative disorders, announced today that Dr. Maria Maccecchini, CEO, will be presenting new data on its lead compound "Posiphen® Recovers Memory, Learning and Brain Function in Alzheimer Transgenic Mice" at the 12th Annual Biotech Symposium, taking place October 22, 2012 in Philadelphia, PA.

Lentigen awarded $1.23M grant under Patient Protection and Affordable Care Act

Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery products, announced today that it will receive $1,235,306 in cash grants from the U.S. Government under the Patient Protection and Affordable Care Act.

Read more Medical News

› Verified 4 days ago

• 1
• 2
• 3(current)